Avigal Soreq, President and Chief Executive Officer of Delek US Holdings (NASDAQ:DK), disposed of 50,000 shares of common stock on March 3, 2026, for a total of approximately $2,054,157. The sale was carried out in three tranches and occurred while the stock was trading close to its 52-week high of $45.74, following a roughly 216% return over the previous 12 months.
The transactions were split across three executions. The first tranche consisted of 13,768 shares sold at a weighted average price of $41.71, with execution prices ranging from $41.36 to $42.35. The second tranche involved 34,332 shares sold at an average price of $40.90, with prices spanning $40.34 to $41.34. The final tranche saw 1,900 shares sold at an average of $39.85, with trade prices between $39.70 and $40.33.
Following these sales, Soreq's direct ownership in Delek US Holdings stands at 251,678 shares. The dispositions were made pursuant to a pre-arranged 10b5-1 trading plan that was adopted on December 3, 2025.
Independent valuation analysis referenced in available research indicates the stock currently appears overvalued relative to its Fair Value. That same research source offers a Pro Research Report that covers Delek and more than 1,400 other U.S. equities for readers seeking additional valuation and performance detail.
In corporate results released for the fourth quarter of 2025, Delek US Holdings reported earnings per share of $2.31. That EPS figure materially outpaced analyst expectations, which had forecast a loss of $0.07 per share, representing a positive surprise of approximately 3,400% relative to the consensus estimate.
Revenue for the quarter was $2.43 billion, coming in below the $2.55 billion that analysts had expected. That shortfall equated to a negative surprise of about 4.71%. The combined outcome - a sizeable EPS beat alongside a revenue miss - highlights divergent performance signals in the quarter, with profitability metrics stronger than anticipated while top-line receipts lagged forecasts.
The earnings release and the insider sale have drawn attention among market participants and analysts. The information available does not specify any immediate analyst rating changes tied to the results, though the sizable EPS beat is likely to factor into market assessments going forward. Investors and observers will be watching for subsequent developments and additional disclosures from the company.